2nd Quarter - Report — FABIANI & COMPANY for 3-V BIOSCIENCES, INC. (2010)

A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.

Firm

FABIANI & COMPANY

Client

3-V BIOSCIENCES, INC.

Income

$50,000

Expenses

—

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing	Filed	Amount	Counted
2nd Quarter - Report (this page)	Jul 20, 2010	$50,000	Replaced
2nd Quarter - Termination Amendment	Oct 20, 2010	$50,000	Yes

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Defense DEF

Pursuing government funding to support therapeutic platform development for infectious diseases

Lobbyist	Covered position, as disclosed
ELIZABETH BARROWS	—
WENDY SHELTON	—

Contacted: Health & Human Services, Dept of (HHS); Defense, Dept of (DOD); Natl Institutes of Health (NIH); SENATE; HOUSE OF REPRESENTATIVES

Health Issues HCR

Pursuing government funding to support therapeutic platform development for infectious diseases

Lobbyist	Covered position, as disclosed
ELIZABETH BARROWS	—
WENDY SHELTON	—

Contacted: Health & Human Services, Dept of (HHS); Natl Institutes of Health (NIH); SENATE; Defense, Dept of (DOD); HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.